Clinical trial Nivothym
Single-arm, multicenter, phase II study of nivolumab in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy - (Nivothym)
Cancers | |
---|---|
Organ | Thymus |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | EORTC |
EudraCT Identifier | 2015-005504-28 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03134118 |
Inclusion criteria | second line metastatic |
Last update |